|
|
|
|
| Advertisement |
 |
|
|
| Top Feature |
|
|
Presidential Candidates & Rx Policy |
Tom Norton
As the nation heads towards its first presidential primaries of the 2016 election, it’s important for American pharm execs to consider where the leading candidates stand on U.S. Rx policy. Tom Norton takes a closer look
... /Read more/ |
|
|
| Regulatory |
|
|
Congress to Keep a Close Watch on FDA |
With complaints about too-high drug prices remaining a hot topic on Capitol Hill, GOP critics of FDA are planning more oversight of regulatory programs and policies. Jill Wechsler reports
... /Read more/ |
|
| Advertisement |
In their efforts to manage costs, payers and other stakeholders are making bold moves that threaten to create unprecedented challenges to market access for oncology products. Payers are reimbursing providers for following specific clinical pathways, potentially influencing treatment and timing decisions as never before.
Read the article  Oncology Market Access at Risk: Is a Carrot for MDs a Stick for Pharma Companies |
|
| Emerging Markets |
|
|
CEO Profile: Subhanu Saxena, Cipla
|
Pharm Exec sits down with Subhanu Saxena for an update on Cipla's plans to leverage its historic visibility as an emerging market champion to the next level of global leadership in biopharma
... /Read more/ |
|
|
| Special Feature |
|
|
Feeling the Heat: Pharm Exec’s 2016 Industry Forecast
|
In 2016 the industry is going to be tested by regulators, patients, and payers with the high expectations commensurate with drug innovation’s status as a “public good.” Can it reclaim a semblance of public approval by confronting its pricing demons and focusing on innovation and a fresh, patient-first message?
... /Read more/ |
|
|
|
| Industry update |
| //Aduro Biotech (Berkeley, CA) announced that Aimee Luck Murphy has been promoted to the position of Vice President of Clinical Development and Operations.//Vertice Pharma (Berkeley Heights, NJ) named Dr. Indranil Nandi as Vice President, Research & Development.//Ipsos InnoQuest (New York, NY) appointed Linda Lee as President, Global Solutions.//Collegium Pharmaceutical (Canton, MA) appointed Ted Schroeder to its Board of Directors.// |
|
|
| Advertisement |
 |
|
|
| |
|
|
